Skip to main content

Table 1 Summary of patient characteristics

From: Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study

 

GLOBAL (All etiologies)

(n = 682)

Gastroenteritis by rotavirus

(n = 207)

Gastroenteritis by other etiologies

(n = 428)

P

Age (months)

   

0.563

0-6 months

111 (16.3%)

28 (13.5%)

75 (17.5%)

 

7-12 months

141(20.7%)

42 (20.3%)

89 (20.8%)

 

13-24 months

253 (37.1%)

81 (39.1%)

152 (35.5%)

 

25-36 months

109 (16.0%)

38 (18.4%)

67 (15.7%)

 

37-60 months

68 (10.0%)

18 (8.7%)

45 (10.5%)

 

Sex (male %)

383 (56.2%)

116 (56.0%)

241 (56.3%)

0.949

Rotavirus vaccination (complete or partial vaccination)

178 (26.1%)

11 (5.3%)

159 (37.1%)

< 0.001

Maximum number of depositions in 24 hours

6.9 ± 3.4 (6.0)

8.0 ± 4.0 (7.0)

6.3 ± 3.0 (6.0)

< 0.001

Number of times needed medical care

2.1 ± 1.2 (2.0)

2.3 ± 1.3 (2.0)

2.0 ± 1.2 (2.0)

< 0.001

Gastroenteritis episode duration (days)

7.3 ± 3.5 (7.0)

7.6 ± 2.9 (7.0)

7.2 ± 3.7 (6.0)

0.132

Hospital admission

163 (23.9%)

99 (47.8%)

60 (14.0%)

< 0.001

Length of hospital stay (days)

4.4 ± 2.1 (4.0)

4.5 ± 2.1 (4.0)

4.4 ± 2.1 (4.0)

0.850

  1. "Global" represents all patients included in the study. P values are provided for comparison between rotavirus and other etiologies subgroups.